Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
暂无分享,去创建一个
A. Riva | R. Levine | W. Chatila | R. Yaeger | O. Guryanova | C. Jobin | R. Bowman | Daniel Kopinke | D. Avram | Walid K. Chatila | Yang Feng | Daniil E. Shabashvili | Ashley Zuniga | Heidi L Casellas Román | Kartika Venugopal | Troy M Robinson | Rachel C. Newsome | Kendra Hall | Cassandra M Bernsten | Kathryn I. Krajcik | Chamara Gunaratne | Zachary Zaroogian | T. Robinson | D. Kopinke | Ashley N Zuniga | Kendra N Hall | Kathryn I Krajcik | Zachary J Zaroogian | Heidi L Casellas Roman | R. Levine
[1] D. Neuberg,et al. TET2-mutant clonal hematopoiesis and risk of gout , 2022, Blood.
[2] Emily F. Calderbank,et al. Clonal dynamics of haematopoiesis across the human lifespan , 2021, Nature.
[3] D. Christiani,et al. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors , 2021, Cancer Research.
[4] Shannon K. Boi,et al. Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity , 2021, Science Translational Medicine.
[5] David M. Evans,et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis , 2021, The Journal of experimental medicine.
[6] Sina A. Gharib,et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease , 2021, Blood.
[7] W. Tapper,et al. Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease , 2021, Leukemia.
[8] R. Majeti,et al. Clonal hematopoiesis: from mechanisms to clinical intervention. , 2021, Cancer discovery.
[9] P. Campbell,et al. The longitudinal dynamics and natural history of clonal haematopoiesis , 2021, Nature.
[10] R. Marioni,et al. Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects , 2021, Nature Medicine.
[11] C. Benner,et al. DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells , 2021, The Journal of experimental medicine.
[12] J. Vonk,et al. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years. , 2021, Blood advances.
[13] M. Kimmel,et al. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling. , 2021, Cell stem cell.
[14] Ivana V. Yang,et al. Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes , 2021, Nature.
[15] Y. Takeishi,et al. Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease , 2021, JACC. CardioOncology.
[16] P. Awadalla,et al. Clonal hematopoiesis is associated with risk of severe Covid-19 , 2020, Nature Communications.
[17] Stuart M. Gardos,et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis , 2020, Nature Genetics.
[18] O. Guryanova,et al. Alterations to DNMT3A in Hematologic Malignancies , 2020, Cancer Research.
[19] C. Deswarte,et al. High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers. , 2020, Blood Advances.
[20] W. Tapper,et al. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking , 2020, Leukemia.
[21] M. Berger,et al. The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis. , 2020 .
[22] T. Druley,et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis , 2020, Science.
[23] O. Sansom,et al. WNT and β-Catenin in Cancer: Genes and Therapy , 2020, Annual Review of Cancer Biology.
[24] N. Schultz,et al. Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis. , 2020, Clinical colorectal cancer.
[25] Monjur Ahmed. Colon Cancer: A Clinician’s Perspective in 2019 , 2020, Gastroenterology research.
[26] Christopher A. Miller,et al. Remethylation of Dnmt3a−/− hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing , 2020, Proceedings of the National Academy of Sciences.
[27] M. Goodell,et al. Environmental Influences on Clonal Hematopoiesis. , 2019, Experimental hematology.
[28] D. Spencer,et al. Inflammatory Cytokines Promote Clonal Hematopoiesis with Specific Mutations in Ulcerative Colitis Patients. , 2019, Experimental hematology.
[29] B. Ebert,et al. Clonal hematopoiesis in human aging and disease , 2019, Science.
[30] S. Fichtlscherer,et al. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation , 2019, European heart journal.
[31] E. Giovannucci,et al. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.
[32] E. Papaemmanuil,et al. Managing Clonal Hematopoiesis in Patients With Solid Tumors. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] B. Brüne,et al. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.
[34] M. Castro,et al. Mouse Model of Colitis-Associated Colorectal Cancer (CAC): Isolation and Characterization of Mucosal-Associated Lymphoid Cells. , 2018, Methods in molecular biology.
[35] J. Reis-Filho,et al. Evaluating clonal hematopoiesis in tumor infiltrating leukocytes in breast cancer and secondary hematologic malignancies. , 2019, Journal of the National Cancer Institute.
[36] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[37] P. Libby,et al. Loss-of-Function Mutations in Dnmt3a and Tet2 Lead to Accelerated Atherosclerosis and Convergent Macrophage Phenotypes in Mice , 2018, Blood.
[38] P. A. Futreal,et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy , 2018, Cell stem cell.
[39] M. Ladanyi,et al. Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors , 2018, JAMA oncology.
[40] M. Casey,et al. Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] Peter Guttorp,et al. Visualizing hematopoiesis as a stochastic process. , 2018, Blood advances.
[42] Peter J. Campbell,et al. Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.
[43] Stanley W. K. Ng,et al. Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.
[44] K. Ballman,et al. Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.
[45] D. Hayes,et al. Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays , 2018, Clinical Cancer Research.
[46] J. Ross,et al. Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens. , 2018, Blood.
[47] Wei Li,et al. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo , 2018, Cell reports.
[48] D. Goukassian,et al. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.
[49] R. Levine,et al. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. , 2018, Cell stem cell.
[50] Christopher A. Miller,et al. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential , 2018, Nature Communications.
[51] T. Putoczki,et al. In Vivo Models of Inflammatory Bowel Disease and Colitis-Associated Cancer. , 2018, Methods in molecular biology.
[52] M. Ladanyi,et al. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.
[53] Kari Stefansson,et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.
[54] M. Dubé,et al. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.
[55] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[56] Matthew A. Cooper,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.
[57] R. Wilson,et al. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression , 2017, Cell.
[58] C. Balestrieri,et al. Dnmt3a restrains mast cell inflammatory responses , 2017, Proceedings of the National Academy of Sciences.
[59] S. Manley,et al. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel. , 2017, Cancer genetics.
[60] M. Goodell,et al. DNMT3A in Leukemia. , 2017, Cold Spring Harbor perspectives in medicine.
[61] H. McLeod,et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. , 2017, The Lancet. Oncology.
[62] Francine E. Garrett-Bakelman,et al. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling , 2016, Nature Medicine.
[63] T. Druley,et al. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.
[64] T. Walsh,et al. Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma. , 2016, JAMA oncology.
[65] Francine E. Garrett-Bakelman,et al. Dnmt3a Regulates Myeloproliferation and Liver-Specific Expansion of Hematopoietic Stem and Progenitor Cells , 2015, Leukemia.
[66] Caitlyn W. Barrett,et al. AOM/DSS Model of Colitis-Associated Cancer. , 2016, Methods in molecular biology.
[67] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[68] R. McIntyre,et al. Mouse models of colorectal cancer as preclinical models , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.
[69] A. Viale,et al. Somatic mutations in leukocytes infiltrating primary breast cancers , 2015, npj Breast Cancer.
[70] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[71] Laurent Beaugerie,et al. Cancers complicating inflammatory bowel disease. , 2015, The New England journal of medicine.
[72] D. Butkiewicz,et al. Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients , 2015, British Journal of Cancer.
[73] E. Zeggini,et al. Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.
[74] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[75] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[76] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[77] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[78] Thomas J. Hudson,et al. Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia , 2014, Nature.
[79] I. Weissman,et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.
[80] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[81] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[82] M. Goodell,et al. Flow cytometry analysis of murine hematopoietic stem cells , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[83] Belgin Dogan,et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.
[84] Mithat Gonen,et al. Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.
[85] I. Weissman,et al. Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.
[86] Veronika Rockova,et al. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. , 2012, Blood.
[87] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[88] J. Berg,et al. Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.
[89] M. Gore,et al. Axitinib for the Management of Metastatic Renal Cell Carcinoma , 2011, Drugs in R&D.
[90] J. Licht,et al. DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.
[91] Yong-mei Zhu,et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.
[92] S. Morini,et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies , 2011, Journal of carcinogenesis.
[93] Li Ding,et al. Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes , 2011, Leukemia.
[94] H. Herfarth,et al. Gnotobiotic IL-10−/−; NF-κBEGFP Mice Develop Rapid and Severe Colitis Following Campylobacter jejuni Infection , 2009, PloS one.
[95] H. Herfarth,et al. Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility , 2009, PloS one.
[96] R. Jaenisch,et al. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[97] M. Neurath,et al. High resolution colonoscopy in live mice , 2006, Nature Protocols.
[98] C. Jobin,et al. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. , 2007, Journal of immunology.
[99] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[100] Takuji Tanaka,et al. A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate , 2003, Cancer science.
[101] E. Bloemena,et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines , 1998, Clinical and experimental immunology.
[102] D. Gilliland,et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. , 1996, Blood.
[103] H. Cooper,et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[104] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.